✦ LIBER ✦

A Phase II, Randomized, Double-Blind, Multicenter, Based on Standard Therapy, Placebo-Controlled Study of the Efficacy and Safety of Recombinant Human Neuregulin-1 in Patients With Chronic Heart Failure

✍ Scribed by Runlin Gao; Jian Zhang; Liuquan Cheng; Xuesi Wu; Wei Dong; Xinchun Yang; Tianchang Li; Xifu Liu; Yabei Xu; Xinyan Li; Mingdong Zhou

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multicenter, randomized, placebo-control

✍ Antonio Circo; Francesco Platania; Salvatore Mangiameli; Ernesto Putignano 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 764 KB

Efficacy and safety of a short-term (6-h

✍ Steven B Gollub; Uri Elkayam; James B Young; Leslie W Miller; Karen A Haffey 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 423 KB

A multicenter, randomized, placebo-contr

✍ E. J. Rhee; W. Y. Lee; K. H. Yoon; S. J. Yoo; I. K. Lee; S. H. Baik; Y. K. Kim; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 531 KB

A phase II, double-blind, randomized, pl

✍ Michael Zile; William Gaasch; William Little; Gary Francis; Luigi Tavazzi; John 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 108 KB

The Effects of Aldosterone Synthase Inhi

✍ Karl Andersen; Daniel Hartman; Thomas Peppard; David Hermann; Peter Van Ess; Mar 📂 Article 📅 2012 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 331 KB

Rationale and study design for a multice

✍ Mihai Gheorghiade; Wendy A. Gattis; Alejandro Barbagelata; Kirkwood F. Adams Jr; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 76 KB